Outcomes of Uterine Conservation in Placenta Accreta Spectrum

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on patients diagnosed with placenta accreta spectrum who undergo uterine conservation procedures. It aims to document the immediate outcomes of these procedures, including success rates, blood loss, and transfusion requirements. Participants will be monitored for the return of menstruation and any uterine abnormalities through ultrasound or hysteroscopy. Data will be collected on various factors such as obstetric history, anthropometry, and laboratory investigations to assess the overall impact of the intervention.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* • Diagnosed sonographically to have placenta accreta spectrum.

  * Pregnancy is singleton and fetus is alive.
  * Elective caesarean section done from 35 gestational weeks.

Exclusion Criteria:

* • Patients requesting hysterectomy.

  * Coexisting uterine pathology such as fibroids or gynaecological malignancies.
  * Patients with bleeding diathesis.
  * Morbid obesity of BMI \>40.
  * Patients having labour pains or vaginal bleeding before scheduled intervention.

Where it's running

• Faculty of Medicine
  Alexandria, Alexandria Governorate, Egypt Recruiting

Study contacts

• Study coordinator: Omar Y Elshorbagy, As.lec
• Email: o_kamal13@alexmed.edu.eg
• Phone: 01111362322

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Vision Transformer–based ultrasound AI to detect placenta accreta spectrum

  A AI tool uses ultrasound video inputs to help see if the placenta is abnormally attached during pregnancy in women at risk.

  Recruiting The Third Affiliated Hospital of Guangzhou Medical University · Guangzhou, Guangdong · NCT07643090

• Three conservative surgeries for placenta accreta spectrum: a comparison

  Researchers compare three uterus-preserving surgical options to see which works best for placenta accreta spectrum.

  Recruiting Assiut University · Asyut · NCT07520201

• Planned cesarean at 37 weeks versus 36 weeks for pregnancies with placenta previa and accreta

  We will test whether scheduling cesarean delivery at 37 weeks instead of 36 weeks helps newborns without increasing maternal bleeding in pregnant women with placenta previa and accreta.

  Recruiting The Third Affiliated Hospital of Guangzhou Medical University · Guangzhou, Guangdong and 5 other locations · NCT07025954

• High versus low segmental hysterotomy and uterine scar defects after a first cesarean

  We will test whether high or low segmental hysterotomy, with or without cross-suturing, leads to fewer uterine scar defects in people having their first cesarean.

  Recruiting Fundacion Clinica Valle del Lili · Cali, Valle del Cauca Department · NCT06620432

• Managing placenta accreta spectrum while preserving the uterus

  This study is testing a new way to manage placenta accreta spectrum disorders by allowing some women to keep their uterus after delivery instead of having surgery, to see if it can be a safer option for them.

  Recruiting University of Pennsylvania · Philadelphia, Pennsylvania · NCT06512181

• An anatomical system to guide surgery for placenta accreta

  This project will try using an intraoperative anatomical classification to help surgeons choose the safest operation for pregnant people at risk of placenta accreta.

  Recruiting University of California, Los Angeles · Los Angeles, California · NCT07283042

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.